Hints and tips:
Related Special Reports
...Health authorities had also hoped it could help sway sceptics who preferred not to receive an mRNA vaccine, though demand has since collapsed....
...While some investors are sceptical of companies without long-term growth plans, she said Moderna had met every challenge....
...Cuban is targeting the 38 per cent of private sector employers who self-insure at least one of their health plans....
...Przybelski, at UW Health, said about half his patients were initially refused by Medicare Advantage plans for PET scan coverage, adding that “it normally involves a long phone call” to get scans approved...
...It has abandoned plans for two treatments already. It is working on developing a once-a-day version of its own obesity pill danuglipron after dropping plans for a twice-daily pill....
...Last month CubicPV, a Bill Gates-backed manufacturer of wafers for solar panels, scrapped plans to build a 10GW US factory announced in December 2022, citing a “dramatic collapse” in prices....
...were put on some form of performance management plan or facing dismissal....
...Massie said Scalise had “not articulated a viable plan” for passing an alternative to the typical, massive end-of-year spending bill....
...Hang it on Hunt’s announcement of an NHS productivity plan. I want to turn their thoughts into a pamphlet. A manifesto for AI in the NHS; or maybe it’s the AINHS; the NAIHS?...
...Pfizer is abandoning its plans for a weight loss pill to be taken twice a day after trials showed it caused significant side effects, in a setback to the US drugmaker’s effort to enter the fast-growing market...
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance giant, according to people familiar with the matter....
...“No company involved in the Federated Data Platform can access health and care data without the explicit permission of the NHS,” it added....
...To make up for the shortfall in its pipeline, the US drugmaker earlier this year announced plans to buy Seagen, an oncology drugmaker, for $43bn; a deal Pfizer said it expected to close on Thursday....
...For many farmers, regenerative agriculture is more to do with the health of their land than of their bank balances....
...Pfizer and BioNTech each receive half of the gross profits of the vaccine. The US group plans to cut about $1bn in costs this year....
...Roche plans to buy immunology company Telavant from Roivant Sciences and Pfizer for more than $7bn, as the drugmaker’s new chief executive seeks to replenish its drug pipeline....
...With the new building, MSD plans to bring together scientists scattered at several sites around the King’s Cross area and more than double the number of its researchers in London....
...Companies embracing AI stress that security and privacy are their top priority, as these devices run the gamut from cameras that scan your home to sensors that detect the most personal of health indicators...
...But early indications of MA enrolment for 2024 have not been great, and if that plays out, Cigna’s greater exposure to commercial health plans may turn into a relative advantage....
...He tried to talk to the store manager about the danger of mislabelling food products but didn’t get far. So he submitted an official complaint to the county health department....
...The news from Texas: Charif Souki, the godfather of US liquefied natural gas, is out at Tellurian as the developer struggles to get its Louisiana export megaproject off ground....
...In 2020, Pfizer spun off its generics business Upjohn, combining it with Mylan to form Viatris, while Johnson & Johnson, GSK, Pfizer and Novartis have all shed their consumer health businesses selling over-the-counter...
...heart of its business plan — and luxury showrooms....
...Residents living near the plant, many in a black township built downwind of the plant during apartheid, complain of health issues related to air quality....
...One thing to start: Cigna is in talks to merge with Humana in a deal that would create a US health insurance giant worth $140bn and provide a significant test for antitrust authorities, according to people...
International Edition